The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Lilly; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Lilly; MSD; Roche
Speakers' Bureau - AstraZeneca; Lilly; MSD; Roche
Expert Testimony - AstraZeneca; Lilly; MSD; Roche
Travel, Accommodations, Expenses - AstraZeneca; Lilly; MSD; Roche
Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A randomized phase 2 study (GOAL, Spanish Lung Cancer Group).
 
Rosario Garcia Campelo
No Relationships to Disclose
 
Oscar Gerardo Arrieta Rodriguez
No Relationships to Disclose
 
Bartomeu Massuti
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Merck Serono; Pfizer; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Janssen; Merck Sharp & Dohme; Roche
 
Delvys Rodriguez-Abreu
Consulting or Advisory Role - Hoffmann-La Roche, Bristol-Myers Squibb, MSD, Boehringer- Ingelheim
Speakers' Bureau - Hoffmann-La Roche, Bristol-Myers Squibb, MSD, Boehringer- Ingelheim
Travel, Accommodations, Expenses - Hoffmann-La Roche, Bristol-Myers Squibb, MSD, Boehringer- Ingelheim
 
Ana Laura Ortega Granados
No Relationships to Disclose
 
Margarita Majem
No Relationships to Disclose
 
David Vicente
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca; Roche
 
Pilar Lianes
No Relationships to Disclose
 
Joaquim Bosch-Barrera
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pierre Fabre; Roche
Research Funding - Boehringer Ingelheim
 
Amelia Insa
No Relationships to Disclose
 
Manuel Domine
No Relationships to Disclose
 
Noemi Reguart
No Relationships to Disclose
 
Maria Guirado
No Relationships to Disclose
 
María Ángeles Sala
No Relationships to Disclose
 
Sergio Vazquez-Estevez
Consulting or Advisory Role - Astellas Oncology; AstraZeneca; Bristol-Myers Squibb; Lilly; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Reyes Bernabe Caro
No Relationships to Disclose
 
Ana Drozdowskyj
No Relationships to Disclose
 
Ana Verdu
No Relationships to Disclose
 
Niki Karachaliou
No Relationships to Disclose
 
Rafael Rosell
No Relationships to Disclose